CTIS2024-513719-28-00进行中（未招募）1 期
RECURrence of Atrial Fibrillation after cardioversion of patients randomized to open-label treatment with dapagliflozin or usual care (RECUR-AF)
Karolinska University Hospital0 个研究点目标入组 1,600 人开始时间: 2024年5月31日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Patients with AF on ECG who are planned for electrical cardioversion within 7-26 from inclusion-date., Age = 55 years., The subject has given their written consent to participate in the trial.
排除标准
- •Current treatment with SGLT2 inhibitor (dapagliflozin, empagliflozin, canagliflozin, sotagliflozin)., Prior/current diagnosis of heart failure., Type 1 diabetes mellitus., Estimated glomerular filtration rate (eGFR) < 25 ml/min/1.73m2., Pulmonary vein isolation within last 3 months or planned pulmonary vein isolation within study period (56 days)., Contraindications to SGLT2 inhibitors (dapagliflozin, empagliflozin, canagliflozin, sotagliflozin)., Any condition or circumstance in which the patient should not participate in the study according to the study investigator.
研究者
相似试验
尚未招募
不适用
se of Smartphone Application to Detect Atrial Fibrillation After Ablation ProcedureCardiovascular - Other cardiovascular diseasesAtrial FibrillationACTRN12622000887774IVERSITY OF ADELAIDE98
已完成
不适用
Predictors of recurrence after atrial fibrillation ablatioatrial fibrillation ablationJPRN-UMIN000048324Showa University Yokohama Northern Hospital100
尚未招募
不适用
Observational study of recurrence of atrial fibrillation after lung resection operatioung tumorJPRN-UMIN000048824Wakayama Medical University1,300
尚未招募
不适用
Observational study of recurrence of atrial fibrillation after esophageal cancer operatioEsophageal cancerJPRN-UMIN000047761Wakayama Medical University415
尚未招募
Unknown
Post operative occurrence of atrial fibrillation and risk factor analysis among patients undergoing coronary artery bypass grafting in a tertiary care hospital.CTRI/2023/05/052175Dr Pallavi Mishra